Metropolis Healthcare on Tuesday mentioned its consolidated web revenue declined 19 per cent to Rs 29 crore within the fourth quarter ended March quarter 2025. The diagnostics chain had reported a web revenue of Rs 36 crore for the January-March interval of FY24.
Income from operations rose to Rs 345 crore within the interval beneath assessment from Rs 331 crore within the year-ago interval, Metropolis Healthcare mentioned in a regulatory submitting.
For FY25, the corporate reported a web revenue of Rs 146 crore as in contrast with Rs 128 crore in 2023-24.
The corporate mentioned its board has accredited the re-appointment of Ameera Shah as Chairperson and Complete-time Director of the corporate for 5 years with impact from March 18, 2026.
The board additionally appointed Surendran Chemmenkotil, at the moment serving as CEO, as Managing Director for 3 years with impact from June 1, 2025.
Shares of Metropolis on Tuesday ended 0.66 per cent down at Rs 1,701.85 apiece on BSE.
